Condition: Diabetes Mellitus, Type 1 · Sponsor: Novo Nordisk A/S
The purpose of the study is to investigate the safety and effectiveness of Awiqli in participants with diabetes mellitus under real world clinical practice in Japan. Participants will get Awiqli as prescribed by the study doctor. The study will last for about 1 year.
This description comes directly from the study's public registry record.
Novo Nordisk · (+1) 866-867-7178 · clinicaltrials@novonordisk.com
Always discuss trial participation with your own doctor first.
| Seino Internal Medicine Clinic_Internal medicine | Koriyama-shi, Fukushima, Fukushima, Japan, Japan | Enrolling By Invitation |
| Abe Diabetes Clinic_Internal Medicine | Oita-shi, Oita,, Japan, Japan | Enrolling By Invitation |
| Jinnouchi Hospital_Internal Medicine | Kumamoto, Kumamoto, Japan, Japan | Enrolling By Invitation |
| Miyachi Clinic | Aichi, Japan | Enrolling By Invitation |
| Clinic Tosaki | Aichi, Japan | Enrolling By Invitation |
| Fukuoka Naika Clinic_Internal Medicine | Aichi, Japan | Enrolling By Invitation |
| Hattori Clinic Chiryu_Diabetes and Endocrinology | Aichi, Japan | Enrolling By Invitation |
| Uenishi Internal Medicine Clinic | Aichi, Japan | Enrolling By Invitation |
| Ichinomiyanishi Hospital | Aichi, Japan | Enrolling By Invitation |
| Ohisama Clinic_Aomori | Aomori, Japan | Enrolling By Invitation |
| Kakizaki Tonyobyo Naika Clinic | Aomori, Japan | Recruiting |
| Chiba Central Medical Center | Chiba, Japan | Enrolling By Invitation |
+ 100 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06807190